HEADER TRANSCRIPTION/TRANSCRIPTION INHIBITOR 16-NOV-17 6BN6 TITLE IDENTIFICATION OF BICYCLIC HEXAFLUOROISOPROPYL ALCOHOL SULFONAMIDES AS TITLE 2 RORGT/RORC INVERSE AGONISTS COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN; COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 6 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 7 ORPHAN RECEPTOR-GAMMA; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RORGT, NUCLEAR HORMONE RECEPTOR, LIGAND-BINDING DOMAIN, INVERSE KEYWDS 2 AGONIST, TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.SACK REVDAT 4 13-MAR-24 6BN6 1 REMARK REVDAT 3 03-JAN-18 6BN6 1 JRNL REVDAT 2 27-DEC-17 6BN6 1 JRNL REVDAT 1 20-DEC-17 6BN6 0 JRNL AUTH H.GONG,D.S.WEINSTEIN,Z.LU,J.J.DUAN,S.STACHURA,L.HAQUE, JRNL AUTH 2 A.KARMAKAR,H.HEMAGIRI,D.K.RAUT,A.K.GUPTA,J.KHAN,D.CAMAC, JRNL AUTH 3 J.S.SACK,A.PUDZIANOWSKI,D.R.WU,M.YARDE,D.R.SHEN,V.BOROWSKI, JRNL AUTH 4 J.H.XIE,H.SUN,C.D'ARIENZO,M.DABROS,M.A.GALELLA,F.WANG, JRNL AUTH 5 C.A.WEIGELT,Q.ZHAO,W.FOSTER,J.E.SOMERVILLE,L.M.SALTER-CID, JRNL AUTH 6 J.C.BARRISH,P.H.CARTER,T.G.M.DHAR JRNL TITL IDENTIFICATION OF BICYCLIC HEXAFLUOROISOPROPYL ALCOHOL JRNL TITL 2 SULFONAMIDES AS RETINOIC ACID RECEPTOR-RELATED ORPHAN JRNL TITL 3 RECEPTOR GAMMA (ROR GAMMA /RORC) INVERSE AGONISTS. EMPLOYING JRNL TITL 4 STRUCTURE-BASED DRUG DESIGN TO IMPROVE PREGNANE X RECEPTOR JRNL TITL 5 (PXR) SELECTIVITY. JRNL REF BIOORG. MED. CHEM. LETT. V. 28 85 2018 JRNL REFN ESSN 1464-3405 JRNL PMID 29233651 JRNL DOI 10.1016/J.BMCL.2017.12.006 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 28022 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1410 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.49 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.36 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2940 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2302 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2797 REMARK 3 BIN R VALUE (WORKING SET) : 0.2295 REMARK 3 BIN FREE R VALUE : 0.2438 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.86 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 143 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3529 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 93 REMARK 3 SOLVENT ATOMS : 59 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 70.93 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.85180 REMARK 3 B22 (A**2) : -2.85180 REMARK 3 B33 (A**2) : 5.70350 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.244 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.189 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.255 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.194 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3690 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5007 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1295 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 651 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3690 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 466 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4192 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.42 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BN6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1000231164. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-AUG-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28070 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 46.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.20 REMARK 200 R MERGE (I) : 0.03900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 34.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.40 REMARK 200 R MERGE FOR SHELL (I) : 0.54600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 273K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.18333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 84.36667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 63.27500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 105.45833 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 21.09167 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 244 REMARK 465 GLY A 245 REMARK 465 SER A 246 REMARK 465 SER A 247 REMARK 465 HIS A 248 REMARK 465 HIS A 249 REMARK 465 HIS A 250 REMARK 465 HIS A 251 REMARK 465 HIS A 252 REMARK 465 HIS A 253 REMARK 465 SER A 254 REMARK 465 SER A 255 REMARK 465 GLY A 256 REMARK 465 LEU A 257 REMARK 465 VAL A 258 REMARK 465 PRO A 259 REMARK 465 ARG A 260 REMARK 465 GLY A 261 REMARK 465 SER A 262 REMARK 465 HIS A 263 REMARK 465 MET A 264 REMARK 465 VAL A 493 REMARK 465 VAL A 494 REMARK 465 GLN A 495 REMARK 465 ALA A 496 REMARK 465 ALA A 497 REMARK 465 PHE A 498 REMARK 465 PRO A 499 REMARK 465 PRO A 500 REMARK 465 LEU A 501 REMARK 465 TYR A 502 REMARK 465 LYS A 503 REMARK 465 GLU A 504 REMARK 465 LEU A 505 REMARK 465 PHE A 506 REMARK 465 SER A 507 REMARK 465 THR A 508 REMARK 465 MET B 244 REMARK 465 GLY B 245 REMARK 465 SER B 246 REMARK 465 SER B 247 REMARK 465 HIS B 248 REMARK 465 HIS B 249 REMARK 465 HIS B 250 REMARK 465 HIS B 251 REMARK 465 HIS B 252 REMARK 465 HIS B 253 REMARK 465 SER B 254 REMARK 465 SER B 255 REMARK 465 GLY B 256 REMARK 465 LEU B 257 REMARK 465 VAL B 258 REMARK 465 PRO B 259 REMARK 465 ARG B 260 REMARK 465 GLY B 261 REMARK 465 SER B 262 REMARK 465 HIS B 263 REMARK 465 GLN B 487 REMARK 465 HIS B 488 REMARK 465 LEU B 489 REMARK 465 HIS B 490 REMARK 465 PRO B 491 REMARK 465 ILE B 492 REMARK 465 VAL B 493 REMARK 465 VAL B 494 REMARK 465 GLN B 495 REMARK 465 ALA B 496 REMARK 465 ALA B 497 REMARK 465 PHE B 498 REMARK 465 PRO B 499 REMARK 465 PRO B 500 REMARK 465 LEU B 501 REMARK 465 TYR B 502 REMARK 465 LYS B 503 REMARK 465 GLU B 504 REMARK 465 LEU B 505 REMARK 465 PHE B 506 REMARK 465 SER B 507 REMARK 465 THR B 508 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 267 CG CD1 CD2 REMARK 470 GLU A 269 CG CD OE1 OE2 REMARK 470 LYS A 279 CE NZ REMARK 470 ARG A 282 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 302 NE CZ NH1 NH2 REMARK 470 GLU A 303 CG CD OE1 OE2 REMARK 470 LYS A 336 CG CD CE NZ REMARK 470 GLU A 343 CG CD OE1 OE2 REMARK 470 ILE A 350 CG1 CG2 CD1 REMARK 470 ARG A 374 CZ NH1 NH2 REMARK 470 ARG A 437 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 441 CG CD OE1 NE2 REMARK 470 LYS A 456 CG CD CE NZ REMARK 470 LYS A 469 CG CD CE NZ REMARK 470 LYS A 471 CG CD CE NZ REMARK 470 ARG A 473 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 482 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 486 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 487 CG CD OE1 NE2 REMARK 470 HIS A 488 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 490 CG ND1 CD2 CE1 NE2 REMARK 470 PRO A 491 CG CD REMARK 470 ILE A 492 CG1 CG2 CD1 REMARK 470 HIS B 272 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 279 CE NZ REMARK 470 GLU B 290 CG CD OE1 OE2 REMARK 470 ARG B 294 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 302 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 343 CG CD OE1 OE2 REMARK 470 ARG B 437 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 441 CG CD OE1 NE2 REMARK 470 LYS B 469 CG CD CE NZ REMARK 470 LYS B 471 CG CD CE NZ REMARK 470 ARG B 482 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 484 CG CD OE1 NE2 REMARK 470 PHE B 486 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 286 -64.66 74.63 REMARK 500 PHE A 486 7.46 164.94 REMARK 500 GLN A 487 -158.67 165.96 REMARK 500 SER B 266 -152.48 -101.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue XGH A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue XGH B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 603 DBREF 6BN6 A 265 508 UNP P51449 RORG_HUMAN 265 508 DBREF 6BN6 B 265 508 UNP P51449 RORG_HUMAN 265 508 SEQADV 6BN6 MET A 244 UNP P51449 INITIATING METHIONINE SEQADV 6BN6 GLY A 245 UNP P51449 EXPRESSION TAG SEQADV 6BN6 SER A 246 UNP P51449 EXPRESSION TAG SEQADV 6BN6 SER A 247 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS A 248 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS A 249 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS A 250 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS A 251 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS A 252 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS A 253 UNP P51449 EXPRESSION TAG SEQADV 6BN6 SER A 254 UNP P51449 EXPRESSION TAG SEQADV 6BN6 SER A 255 UNP P51449 EXPRESSION TAG SEQADV 6BN6 GLY A 256 UNP P51449 EXPRESSION TAG SEQADV 6BN6 LEU A 257 UNP P51449 EXPRESSION TAG SEQADV 6BN6 VAL A 258 UNP P51449 EXPRESSION TAG SEQADV 6BN6 PRO A 259 UNP P51449 EXPRESSION TAG SEQADV 6BN6 ARG A 260 UNP P51449 EXPRESSION TAG SEQADV 6BN6 GLY A 261 UNP P51449 EXPRESSION TAG SEQADV 6BN6 SER A 262 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS A 263 UNP P51449 EXPRESSION TAG SEQADV 6BN6 MET A 264 UNP P51449 EXPRESSION TAG SEQADV 6BN6 MET B 244 UNP P51449 INITIATING METHIONINE SEQADV 6BN6 GLY B 245 UNP P51449 EXPRESSION TAG SEQADV 6BN6 SER B 246 UNP P51449 EXPRESSION TAG SEQADV 6BN6 SER B 247 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS B 248 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS B 249 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS B 250 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS B 251 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS B 252 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS B 253 UNP P51449 EXPRESSION TAG SEQADV 6BN6 SER B 254 UNP P51449 EXPRESSION TAG SEQADV 6BN6 SER B 255 UNP P51449 EXPRESSION TAG SEQADV 6BN6 GLY B 256 UNP P51449 EXPRESSION TAG SEQADV 6BN6 LEU B 257 UNP P51449 EXPRESSION TAG SEQADV 6BN6 VAL B 258 UNP P51449 EXPRESSION TAG SEQADV 6BN6 PRO B 259 UNP P51449 EXPRESSION TAG SEQADV 6BN6 ARG B 260 UNP P51449 EXPRESSION TAG SEQADV 6BN6 GLY B 261 UNP P51449 EXPRESSION TAG SEQADV 6BN6 SER B 262 UNP P51449 EXPRESSION TAG SEQADV 6BN6 HIS B 263 UNP P51449 EXPRESSION TAG SEQADV 6BN6 MET B 264 UNP P51449 EXPRESSION TAG SEQRES 1 A 265 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 265 LEU VAL PRO ARG GLY SER HIS MET ALA SER LEU THR GLU SEQRES 3 A 265 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 4 A 265 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 5 A 265 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 6 A 265 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 7 A 265 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 8 A 265 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 9 A 265 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 10 A 265 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 11 A 265 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 12 A 265 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 13 A 265 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 14 A 265 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 15 A 265 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 16 A 265 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 17 A 265 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 18 A 265 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 19 A 265 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 20 A 265 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 21 A 265 GLU LEU PHE SER THR SEQRES 1 B 265 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 265 LEU VAL PRO ARG GLY SER HIS MET ALA SER LEU THR GLU SEQRES 3 B 265 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 4 B 265 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 5 B 265 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 6 B 265 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 7 B 265 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 8 B 265 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 9 B 265 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 10 B 265 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 11 B 265 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 12 B 265 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 13 B 265 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 14 B 265 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 15 B 265 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 16 B 265 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 17 B 265 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 18 B 265 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 19 B 265 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 20 B 265 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 21 B 265 GLU LEU PHE SER THR HET XGH A 601 39 HET SO4 A 602 5 HET XGH B 601 39 HET SO4 B 602 5 HET SO4 B 603 5 HETNAM XGH 2-[(2S)-4-[(4-FLUOROPHENYL)SULFONYL]-7-(1,1,1,3,3,3- HETNAM 2 XGH HEXAFLUORO-2-HYDROXYPROPAN-2-YL)-3,4-DIHYDRO-2H-1,4- HETNAM 3 XGH BENZOTHIAZIN-2-YL]-N-(2-HYDROXY-2-METHYLPROPYL) HETNAM 4 XGH ACETAMIDE HETNAM SO4 SULFATE ION FORMUL 3 XGH 2(C23 H23 F7 N2 O5 S2) FORMUL 4 SO4 3(O4 S 2-) FORMUL 8 HOH *59(H2 O) HELIX 1 AA1 SER A 266 GLU A 283 1 18 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 ARG A 296 ASN A 298 5 3 HELIX 4 AA4 SER A 301 LYS A 311 1 11 HELIX 5 AA5 SER A 312 LYS A 336 1 25 HELIX 6 AA6 LEU A 338 GLU A 343 1 6 HELIX 7 AA7 CYS A 345 MET A 365 1 21 HELIX 8 AA8 GLY A 384 GLY A 392 5 9 HELIX 9 AA9 CYS A 393 ALA A 409 1 17 HELIX 10 AB1 SER A 413 ILE A 426 1 14 HELIX 11 AB2 GLU A 435 THR A 457 1 23 HELIX 12 AB3 ARG A 459 LEU A 466 5 8 HELIX 13 AB4 PRO A 468 ILE A 485 1 18 HELIX 14 AB5 SER B 266 GLU B 283 1 18 HELIX 15 AB6 ARG B 288 GLN B 295 1 8 HELIX 16 AB7 ARG B 296 ASN B 298 5 3 HELIX 17 AB8 SER B 301 LYS B 311 1 11 HELIX 18 AB9 SER B 312 LYS B 336 1 25 HELIX 19 AC1 LEU B 338 GLU B 343 1 6 HELIX 20 AC2 CYS B 345 MET B 365 1 21 HELIX 21 AC3 GLY B 384 GLY B 392 5 9 HELIX 22 AC4 CYS B 393 ALA B 409 1 17 HELIX 23 AC5 SER B 413 ILE B 426 1 14 HELIX 24 AC6 GLU B 435 THR B 457 1 23 HELIX 25 AC7 ARG B 459 LEU B 463 5 5 HELIX 26 AC8 PRO B 468 PHE B 486 1 19 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SHEET 1 AA2 3 TYR B 369 ASN B 370 0 SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378 CISPEP 1 ALA B 265 SER B 266 0 6.68 SITE 1 AC1 20 CYS A 285 GLN A 286 TRP A 317 CYS A 320 SITE 2 AC1 20 HIS A 323 LEU A 324 ALA A 327 MET A 358 SITE 3 AC1 20 ARG A 364 MET A 365 ARG A 367 ALA A 368 SITE 4 AC1 20 PHE A 378 PHE A 388 ILE A 397 ILE A 400 SITE 5 AC1 20 PHE A 401 HIS A 479 LEU A 483 HOH A 705 SITE 1 AC2 2 LYS A 354 HIS A 490 SITE 1 AC3 14 TRP B 317 CYS B 320 HIS B 323 LEU B 324 SITE 2 AC3 14 MET B 358 ARG B 364 MET B 365 PHE B 388 SITE 3 AC3 14 LEU B 396 ILE B 397 ILE B 400 PHE B 401 SITE 4 AC3 14 HIS B 479 LEU B 483 SITE 1 AC4 1 LEU B 353 SITE 1 AC5 1 GLN B 349 CRYST1 99.760 99.760 126.550 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010024 0.005787 0.000000 0.00000 SCALE2 0.000000 0.011575 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007902 0.00000